title: Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: a pilot study.
abstract: OBJECTIVE
  We sought to determine satisfaction and continuation rates of the contraceptive implant when placed on the initial visit for first-trimester medical abortion.
  
  
  METHODS
  In this pilot study, we placed the implant within 15 min of mifepristone administration. We assessed satisfaction with implant placement timing, 1-year implant continuation and abortion completion.
  
  
  RESULTS
  We enrolled 20 participants. Sixteen (80%) returned for follow-up, and all had complete abortion. At 1 year, of 16 participants contacted, 14 (87.5%) were satisfied with implant insertion timing, and 14 (87.5%) continued the implant.
  
  
  CONCLUSIONS
  Initiation of the contraceptive implant on the initial visit for medical abortion resulted in high satisfaction and continuation rates.
  
  
  CONCLUSIONS
  This pilot study provides important groundwork for future larger studies to assess initiation of the contraceptive implant on the day of mifepristone for medical abortion.
authors.affiliation: Department of Obstetrics and Gynecology, Boston University Medical Center. Electronic address: Sarita.Sonalkar@bmc.org.
authors.forename: Sarita
authors.initials: S
authors.lastname: Sonalkar
authors.forename: Melody Y
authors.initials: MY
authors.lastname: Hou
authors.forename: Melody
authors.initials: M
authors.lastname: Hou
authors.forename: Lynn
authors.initials: L
authors.lastname: Borgatta
mesh_terms: D000021:Abortifacient Agents, Steroidal; D000032:Abortion, Therapeutic; D000293:Adolescent; D000328:Adult; D001900:Boston; D003268:Contraception Behavior; D003271:Contraceptive Agents, Female / Q000008:administration & dosage* / Q000009:adverse effects; D017135:Desogestrel / Q000008:administration & dosage* / Q000009:adverse effects; D004343:Drug Implants; D005260:Female; D005500:Follow-Up Studies; D006297:Health Services Accessibility; D006801:Humans; D008875:Middle Aged; D015735:Mifepristone; D010342:Patient Acceptance of Health Care; D017060:Patient Satisfaction; D010865:Pilot Projects; D011247:Pregnancy; D013997:Time Factors; D055815:Young Adult
chemical_list: D000021:Abortifacient Agents, Steroidal; D003271:Contraceptive Agents, Female; D004343:Drug Implants; C044815:etonogestrel; D015735:Mifepristone; D017135:Desogestrel
keywords: First-trimester abortion; Long-acting reversible contraception